Clinical trial
A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease
NCT05326009
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedA Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer Diseaseverified · MONDO: Alzheimer disease
Interventions
Sponsors & collaborators
Xuanwu Hospital, Beijinglead sponsor
H. Lundbeck A/Scollaborator
Hoffmann-La Rochecollaborator
Genentech, Inc.collaborator
Lantheus Biosciences Ltd.collaborator
APRINOIA Therapeuticscollaborator
XingImaging, LLCcollaborator
Hangzhou G-Bio Biotechnology Co., Ltdcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05326009 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.